Naturally circulating dendritic cells to vaccinate cancer patients. - Wikidata - wikimedia - TriplyDB

Naturally circulating dendritic cells to vaccinate cancer patients.

Naturally circulating dendritic cells to vaccinate cancer patients.

http://www.wikidata.org/entity/Q40930007

about

Immune response, safety, and survival and quality of life outcomes for advanced colorectal cancer patients treated with dendritic cell vaccine and cytokine-induced killer cell therapy Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines Trial watch: Dendritic cell-based anticancer therapy Past, present and future targets for immunotherapy in ovarian cancer Classification of current anticancer immunotherapies New insights into the phenotype of human dendritic cell populations.Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination.Dendritic cell-based immunotherapy for myeloid leukemias.Dual Functional Capability of Dendritic Cells - Cytokine-Induced Killer Cells in Improving Side Effects of Colorectal Cancer Therapy Dendritic Cell Therapies for Hematologic Malignancies.Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition.Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients Trial watch: Dendritic cell-based interventions for cancer therapy.The Journey of Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and Heterogeneity

P2860

Q21284687-DDC51CEE-CD81-4069-AA0E-4A197FCEA42E Q27013679-2764BB13-453D-495C-B266-30B49D7B50F8 Q27024047-AF02EEC0-4A4C-4F27-AA2D-03A98B2CD6DD Q35034010-0CC9766C-5657-472C-8166-EABD6C112219 Q35149637-82E72334-2203-48AB-858C-66A80B51D391 Q36526496-2C820232-61AC-4775-A700-967A717DD21E Q37224609-7C6C9D42-1F61-471D-A361-7175091A24FE Q37420778-0369B9EF-3679-4EEB-A2F4-1FF99061C727 Q37697390-531DD8BB-CD05-4547-9BF6-CA36BC537065 Q39289930-4D32FB46-94C1-43CD-AD46-22B78A7E3BB7 Q40155520-1056830E-7F20-4DBF-8D69-FDDACE91CEFB Q41967129-B4D6D622-01A1-424F-9151-8074397291AC Q42867339-C3BDD988-4F8D-4914-B4F3-D28FF52AB90C Q58750585-2AB1EC7A-40DA-47FF-AC1C-ABF8A2AE90CF Q58780459-3892C1AE-79FD-46FD-9448-DB58DEFEE945

P2860

Naturally circulating dendritic cells to vaccinate cancer patients.

http://www.wikidata.org/entity/Q40930007

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Naturally circulating dendritic cells to vaccinate cancer patients.

@en

type

label

Naturally circulating dendritic cells to vaccinate cancer patients.

@en

prefLabel

Naturally circulating dendritic cells to vaccinate cancer patients.

@en

P1433

Q40930007-398E9536-9A26-43E8-B9B9-AE0E26A7A057

P1476

Q40930007-2C2A9A04-1A0E-4A16-9879-88BEDC7AAC53

P2093

Q40930007-26973256-532B-4273-92BD-855471D4382B

P2860

Q40930007-0B4DF2CD-1E14-4AE9-818B-6DCB6BB9F650

Q40930007-1B36EA21-6812-459A-9B1A-1A7928FE3778

Q40930007-1E8BA312-EC5B-4882-8AB3-94B802ADE5B9

Q40930007-21C2B84A-9DD9-4082-A438-D355FDA95BD3

Q40930007-35E676A1-C9B3-4518-B495-950F7EBE28CA

Q40930007-472091C3-686F-46CB-B122-6B031B976A27

Q40930007-65D60121-CA46-4AD0-B231-DE617CBD8865

Q40930007-ACE5FDFB-D015-46BE-B007-CE0C30E77D66

Q40930007-D2EDC635-7102-4FF4-BF8B-D856160EBFDC

Q40930007-F0CE38A3-24BD-4F4D-B04E-8EF152EC3BAA

P304

Q40930007-407BB7E0-25BA-4D29-A548-C18E2A3684E5

P31

Q40930007-1F6B4D03-2A48-4B5D-8756-9EC567AFC0F6

P356

Q40930007-A401C0D7-0255-48BA-885D-D2755294505F

P433

Q40930007-936AC832-221A-48FF-A44F-4E3E77D3D43D

P478

Q40930007-A0F2AC04-5090-4BBF-B2CD-986D0BC4E695

P50

Q40930007-1DB693E6-B189-4483-89C9-F38034BE489C

Q40930007-5C452CB9-7F56-4AA4-B85B-245ADD9CDE54

Q40930007-A17E61F2-AABF-4611-B713-FD98F615EA2C

Q40930007-B7F8C0B5-8370-4E30-AF7D-4F99E3DD1548

P577

Q40930007-8CED48AB-BC6F-45C8-92EF-EF7E6B45EE78

P5875

Q40930007-2BAC736A-518D-43F4-82A3-521B21F797AD

P698

Q40930007-2F1E407A-541C-4A39-9708-0E8C40669F1E

P932

Q40930007-7CE595CC-2F8A-4B6E-83BB-A4CD91DCF529

P356

P1433

P1476

Naturally circulating dendritic cells to vaccinate cancer patients

@en

P2093

I Jolanda M de Vries

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer immunotherapy via dendritic cells

Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity.

Targeted antigen delivery and activation of dendritic cells in vivo: steps towards cost effective vaccines.

Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities.

Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses.

Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity.

Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.

Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination.

How many dendritic cells are required to initiate a T-cell response?

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

P304

e23431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/ONCI.23431

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Jolanda de Vries

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

242018019

http://www.w3.org/2001/XMLSchema#string

P698

23802086

http://www.w3.org/2001/XMLSchema#string

P932

3661171

http://www.w3.org/2001/XMLSchema#string